Rothschild Capital Partners’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-63,829
Closed -$5.09M 86
2016
Q3
$5.09M Sell
63,829
-19,500
-23% -$1.57M 1.83% 21
2016
Q2
$6.5M Sell
83,329
-2,301
-3% -$164K 2.51% 14
2016
Q1
$4.71M Hold
85,630
2.11% 19
2015
Q4
$5.29M Sell
85,630
-27
-0% -$1.7K 2.66% 19
2015
Q3
$5.4M Hold
85,657
2.8% 15
2015
Q2
$6.26M Sell
85,657
-994
-1% -$71.8K 2.7% 17
2015
Q1
$5.67M Hold
86,651
2.53% 19
2014
Q4
$5.63M Sell
86,651
-791
-0.9% -$50.9K 2.71% 16
2014
Q3
$5.26M Sell
87,442
-13,885
-14% -$907K 2.42% 22
2014
Q2
$7.02M Sell
101,327
-50
-0% -$3.24K 3.16% 18
2014
Q1
$6.63M Sell
101,377
-1,115
-1% -$72.6K 3.26% 15
2013
Q4
$6.35M Hold
102,492
2.99% 17
2013
Q3
$5.5M Buy
102,492
+4,350
+4% +$224K 2.59% 22
2013
Q2
$4.48M Buy
+98,142
New +$4.25M 2.5% 23

Other funds holding STJ

Rothschild Capital Partners's STJ Position: Q4 2016 in Review

Rothschild Capital Partners sold out of St Jude Medical (STJ) in Q4 2016, closing a stake of 63,829 shares — an estimated $5.09M sold.

Rothschild Capital Partners first reported a position in STJ in Q2 2013 and held it in 14 quarters. The position peaked at $7.02M in Q2 2014. 551 funds tracked by Wall St. Rank hold STJ as of Q4 2016.

  • Rothschild Capital Partners reported no remaining St Jude Medical position as of Q4 2016 after selling out during the quarter.
  • Rothschild Capital Partners sold 63,829 St Jude Medical shares in Q4 2016, an estimated $5.09M.
  • Rothschild Capital Partners first reported a position in St Jude Medical in Q2 2013 and held it in 14 quarters.
  • Rothschild Capital Partners's St Jude Medical position peaked at $7.02M in Q2 2014.
  • 551 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2016.

Based on Rothschild Capital Partners's 13F filing for Q4 2016, filed 30 Jan 2017.